Home▸Articles▸Headache Disorders and Cranial Nerve Conditions

Microvascular Decompression for Trigeminal Neuralgia: A Surgical Approach

Understanding the intricate process of relieving pain by addressing vascular compression on a critical cranial nerve.

mysimulator teamUpdated June 2026≈ 3 min read▶ Open the simulation

What is Microvascular Decompression?

Microvascular decompression (MVD) is a surgical procedure designed to relieve pain associated with trigeminal neuralgia, a condition characterized by severe, episodic facial pain. The procedure involves identifying and addressing the source of compression on the trigeminal nerve, typically from an artery or vein that presses against it.

During MVD, surgeons carefully isolate the affected blood vessel and place a Teflon pad between the nerve and the compressing structure to prevent further irritation.

Why Is It Important?

The importance of microvascular decompression lies in its ability to provide long-term relief from trigeminal neuralgia pain. Unlike medications, which can be less effective over time and may have side effects, MVD offers a more definitive solution by directly addressing the underlying cause.

This procedure is crucial for patients who do not respond well to other treatments or experience significant side effects from medication.

live demo · related simulation● LIVE

The Surgical Procedure

The microvascular decompression surgery involves several stages, each critical in ensuring the effective relief of pain. The procedure begins with a craniotomy, where a small opening is made in the skull to access the brainstem and trigeminal nerve root. This is followed by identifying the compressing vessel and placing a Teflon pad between it and the nerve.

The final stages include closing the dura mater (the outer membrane of the brain), suturing the scalp, and ensuring no bleeding or complications occur post-surgery.

Real-World Applications

Microvascular decompression has been successfully used to treat thousands of patients worldwide. It is particularly effective for those with severe trigeminal neuralgia who have not responded to other treatments such as pharmacotherapy or radiofrequency neuroablation.

The success rate of MVD is high, often leading to significant pain relief and improved quality of life for patients.

Frequently asked questions

What are the risks associated with microvascular decompression?

Risks include infection, bleeding, stroke, and damage to other brain structures. However, these complications are relatively rare, especially when performed by experienced neurosurgeons.

How long does it take to recover from MVD surgery?

Recovery time varies but typically ranges from a few weeks to several months. Patients often experience significant pain relief within days of the procedure, though full recovery can take longer.

Is microvascular decompression suitable for all patients with trigeminal neuralgia?

Not necessarily. MVD is generally recommended for patients who have failed other treatments or those whose symptoms are severe and debilitating. A thorough evaluation by a neurologist or neurosurgeon determines the best course of action.

Can microvascular decompression be performed as an outpatient procedure?

No, MVD is typically an inpatient procedure requiring hospitalization for monitoring and recovery. The complexity and invasiveness of the surgery necessitate close observation post-operation.

Try it live

Everything above runs in your browser — open Microvascular Decompression for Trigeminal Neuralgia Simulator (3D) and change the parameters while it is running. Nothing is installed, nothing is uploaded, the whole model lives in one tab.

▶ Open Microvascular Decompression for Trigeminal Neuralgia Simulator (3D) simulation

What did you find?

Add reproduction steps (optional)